Clinical Trial Update: Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss [NA]

View source ↗

Summary

This completed trial examined whether a low-carbohydrate diet affects weight loss outcomes in people treated with injectable semaglutide for obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: INQUIS Clinical Research | Conditions: Weight Loss | NA | Status: COMPLETED